Pharmaceutical Executive October 28, 2024
The CEO discusses the current state of compounding pharmacies and how it built to this point.
Mark Mikhael, CEO of Olympia Therapeutics, spoke with Pharmaceutical Executive about the compounding industry, which has a renewed spotlight on it due to recent high profile drug shortages.
Pharmaceutical Executive: How did you and Olympia come together?
Mark Mikhael: I started here in January of this year, and it’s been an absolutely amazing ride. There’s a great culture and community. We’re pharmacist owned, and so that really helps to set a great tempo for the organization as well. I graduated with my doctorate in pharmacy in 1999 from Florida A&M University. I’ve been in compounding my entire career, and I’ve really been on the forefront...
Today's Sponsors
Today's Sponsor